Liver Surgery: Current Treatment and Future Options
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Gastroenterology & Hepatology".
Deadline for manuscript submissions: 25 June 2026 | Viewed by 39
Special Issue Editor
Interests: hepatic resection; hepatocellular carcinoma; liver failure; circulating tumor cells; liver transplantation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Liver surgery includes hepatic resection and liver transplantation. Common indications for hepatic resection are hepatocellular carcinoma, liver metastasis from colon cancer, and bile duct origin intrahepatic tumors. Liver transplantation is the only curative treatment option for end-stage liver disease, and it is also an alternative treatment option for hepatocellular carcinoma. There have been many studies on novel challenges and advances in liver surgery, but the field still needs continuous effort and research.
The aim of this Special Issue is to introduce and discuss the current treatment and future options in liver surgery, including hepatic resection and liver transplantation. It includes the study of preoperative diagnosis, perioperative management, surgical techniques and innovations, and prognosis after surgery.
We invite colleagues around the world to share their experience and knowledge on novel challenges and advances in liver disease with original studies, reviews, or communications in order to develop this important field.
Dr. Suk-Won Suh
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liver surgery
- hepatic resection
- liver transplantation
- hepatocellular carcinoma
- liver cirrhosis
- liver failure
- liver metastasis
- cholangiocarcinoma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
